- Home
- IQV vs CQP Comparison
IQV vs CQP Comparison
Compare IQV & CQP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- CQP
- Stock Information
- Founded
- IQV 1982
- CQP 2003
- Country
- IQV United States
- CQP United States
- Employees
- IQV N/A
- CQP N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- CQP Oil/Gas Transmission
- Sector
- IQV Health Care
- CQP Utilities
- Exchange
- IQV Nasdaq
- CQP Nasdaq
- Market Cap
- IQV 31.6B
- CQP 27.8B
- IPO Year
- IQV 2013
- CQP 2007
- Fundamental
- Price
- IQV $150.19
- CQP $59.52
- Analyst Decision
- IQV Buy
- CQP Sell
- Analyst Count
- IQV 20
- CQP 4
- Target Price
- IQV $236.75
- CQP $52.50
- AVG Volume (30 Days)
- IQV 2.4M
- CQP 145.4K
- Earning Date
- IQV 05-06-2025
- CQP 05-02-2025
- Dividend Yield
- IQV N/A
- CQP 5.51%
- EPS Growth
- IQV 2.74
- CQP N/A
- EPS
- IQV 7.49
- CQP 4.26
- Revenue
- IQV $15,405,000,000.00
- CQP $8,704,000,000.00
- Revenue This Year
- IQV $4.08
- CQP $28.04
- Revenue Next Year
- IQV $5.88
- CQP $2.69
- P/E Ratio
- IQV $20.03
- CQP $13.98
- Revenue Growth
- IQV 2.81
- CQP N/A
- 52 Week Low
- IQV $135.97
- CQP $46.71
- 52 Week High
- IQV $252.88
- CQP $68.42
- Technical
- Relative Strength Index (RSI)
- IQV 40.77
- CQP 46.72
- Support Level
- IQV $137.49
- CQP $57.35
- Resistance Level
- IQV $154.17
- CQP $60.06
- Average True Range (ATR)
- IQV 8.48
- CQP 2.96
- MACD
- IQV 1.00
- CQP 0.04
- Stochastic Oscillator
- IQV 58.37
- CQP 65.87
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About CQP Cheniere Energy Partners LP Common Units
Cheniere Energy Partners is the direct owner of the Sabine Pass LNG terminals as well as regasification facilities. It also owns the Creole Trail Pipeline, which connects the terminal to third-party gas suppliers. Cheniere Partners shares in the marketing fees generated by Cheniere Marketing from Sabine Pass marketed gas volumes.